Author:
van Waarde Aren,Absalom Anthony R.,Visser Anniek K. D.,Dierckx Rudi A. J. O.
Publisher
Springer International Publishing
Reference274 articles.
1. Bai LQ, Teng RR, Shiue CY, Wolf AP, Dewey SL, Holland MJ et al (1990) No-carrier-added (NCA) N-(3-[18F]fluoropropyl)-N-norbuprenorphine and N-(3-[18F]fluoropropyl)-N-nordiprenorphine--synthesis, anatomical distribution in mice and rats, and tomographic studies in a baboon. Int J Rad Appl Instrum B 17:217–227
2. Baier B, Bense S, Birklein F, Buchholz HG, Mischke A, Schreckenberger M et al (2010) Evidence for modulation of opioidergic activity in central vestibular processing: A [(18)F] diprenorphine PET study. Hum Brain Mapp 31:550–555
3. Bartenstein PA, Duncan JS, Prevett MC, Cunningham VJ, Fish DR, Jones AK et al (1993) Investigation of the opioid system in absence seizures with positron emission tomography. J Neurol Neurosurg Psychiatry 56:1295–1302
4. Bartenstein PA, Prevett MC, Duncan JS, Hajek M, Wieser HG (1994) Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalohippocampectomy, using positron emission tomography. Epilepsy Res 18:119–125
5. Baumgartner U, Buchholz HG, Bellosevich A, Magerl W, Siessmeier T, Rolke R et al (2006) High opiate receptor binding potential in the human lateral pain system. NeuroImage 30:692–699